BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37471611)

  • 1. Circulating Tumor DNA in Human Papillomavirus-Mediated Oropharynx Cancer: Leveraging Early Data to Inform Future Directions.
    Heft Neal ME; Walline HM; Haring CT
    Cancer J; 2023 Jul-Aug 01; 29(4):215-219. PubMed ID: 37471611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer.
    Regan SN; Mierzwa ML
    Cancer J; 2023 Jul-Aug 01; 29(4):226-229. PubMed ID: 37471613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma.
    Haring CT; Dermody SM; Yalamanchi P; Kang SY; Old MO; Chad Brenner J; Spector ME; Rocco JW
    Oral Oncol; 2022 Mar; 126():105776. PubMed ID: 35183912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
    Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
    Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
    Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
    Galot R; Machiels JH
    Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.
    Burgener JM; Zou J; Zhao Z; Zheng Y; Shen SY; Huang SH; Keshavarzi S; Xu W; Liu FF; Liu G; Waldron JN; Weinreb I; Spreafico A; Siu LL; de Almeida JR; Goldstein DP; Hoffman MM; De Carvalho DD; Bratman SV
    Clin Cancer Res; 2021 Aug; 27(15):4230-4244. PubMed ID: 34158359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer.
    O'Boyle CJ; Siravegna G; Varmeh S; Queenan N; Michel A; Pang KCS; Stein J; Thierauf JC; Sadow PM; Faquin WC; Wang W; Deschler DG; Emerick KS; Varvares MA; Park JC; Clark JR; Chan AW; Busse PM; Corcoran RB; Wirth LJ; Lin DT; Iafrate AJ; Richmon JD; Faden DL
    Cancer; 2022 Jun; 128(11):2193-2204. PubMed ID: 35139236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in head neck cancer: ready for clinical routine diagnostics?
    Tinhofer I; Staudte S; George S
    Curr Opin Oncol; 2023 May; 35(3):151-157. PubMed ID: 36966499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.
    Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T
    Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a high-performance multi-probe droplet digital PCR assay for high-sensitivity detection of human papillomavirus circulating tumor DNA from plasma.
    Bhambhani C; Sandford E; Haring CT; Brummel C; Tuck KL; Olesnavich M; Bhangale AD; Walline HM; Dermody SM; Spector ME; Chinn SB; Casper K; Mierzwa M; Swiecicki PL; Chad Brenner J; Tewari M
    Oral Oncol; 2023 Aug; 143():106436. PubMed ID: 37269557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)-a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma.
    Flach S; Howarth K; Hackinger S; Pipinikas C; Ellis P; McLay K; Marsico G; Forshew T; Walz C; Reichel CA; Gires O; Canis M; Baumeister P
    Br J Cancer; 2022 May; 126(8):1186-1195. PubMed ID: 35132238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Uncertainties of Circulating Tumor DNA in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma in the Absence of National Comprehensive Cancer Network Guidelines.
    Xie DX; Kut C; Quon H; Seiwert TY; D'Souza G; Fakhry C
    J Clin Oncol; 2023 May; 41(14):2483-2487. PubMed ID: 36493337
    [No Abstract]   [Full Text] [Related]  

  • 14. Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma.
    Chikuie N; Urabe Y; Ueda T; Hamamoto T; Taruya T; Kono T; Yumii K; Takeno S
    Sci Rep; 2022 Jun; 12(1):9316. PubMed ID: 35661138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
    Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
    BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
    Economopoulou P; Spathis A; Kotsantis I; Maratou E; Anastasiou M; Moutafi MK; Kirkasiadou M; Pantazopoulos A; Giannakakou M; Edelstein DL; Sloane H; Fredebohm J; Jones FS; Kyriazoglou A; Gavrielatou N; Foukas P; Panayiotides I; Psyrri A
    Oral Oncol; 2023 Apr; 139():106358. PubMed ID: 36871349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.
    Leung E; Han K; Zou J; Zhao Z; Zheng Y; Wang TT; Rostami A; Siu LL; Pugh TJ; Bratman SV
    Clin Cancer Res; 2021 Nov; 27(21):5857-5868. PubMed ID: 34580115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated
    Kampel L; Feldstein S; Tsuriel S; Hannes V; Carmel Neiderman NN; Horowitz G; Warshavsky A; Leider-Trejo L; Hershkovitz D; Muhanna N
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive impact of human papillomavirus circulating tumor DNA in treatment response monitoring of HPV-associated cancers; a meta-analysis on recurrent event endpoints.
    Karimi A; Jafari-Koshki T; Zehtabi M; Kargar F; Gheit T
    Cancer Med; 2023 Sep; 12(17):17592-17602. PubMed ID: 37492996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.